Lv1
90 积分 2022-08-08 加入
Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE
17天前
已完结
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
17天前
已完结
Surrogate End Points in Trials—SPIRIT and CONSORT Extensions
8个月前
已完结
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed
9个月前
已完结
Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments
9个月前
已完结
Common contributing factors of diagnostic error: A retrospective analysis of 109 serious adverse event reports from Dutch hospitals
10个月前
已完结
Burden of serious harms from diagnostic error in the USA
10个月前
已完结
Raising the barcode: improving medication safety behaviours through a behavioural science-informed feedback intervention. A quality improvement project and difference-in-difference analysis
10个月前
已完结
Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study
10个月前
已完结
Management of Candida auris
11个月前
已完结
Aspirin-Triggered Lipoxin Protects Lipopolysaccharide-Induced Acute Kidney Injury via the TLR4/MyD88/NF-kappaB Pathway
皖公网安备34019202002308
